tirzepatide compound availability Ivím Health 1 and GIP therapy Compounded Tirzepatide GLP-1/GIP Care |

Research indicates that individuals using tirzepatide, whether in injectable or oral forms, can experience weight loss ranging from 15% to 20% of their initial body weight over a sustained period

Lilly Rx Only NDC 0002-4523-11 Mounjaro (tirzepatide) injection 50 mg/2.4 mL (20.8 mg/mL) ATTENTION: Contains 4 doses of 12.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient

This compound is provided as a lyophilized powder

For now, the key takeaway is simple: your routine blood work will not reveal whether you are taking tirzepatide

This arrangement allows for a much longer half-life, extending the time between doses, because of its high affinity to albumin